CSCO vs IBM Stock Comparison

Cisco Systems, Inc. vs International Business Machines Corporation

Data as of Sep 2, 2026· market close· Technology· Coverage 54/66 fields· Moderate confidence
AIQ VerdictFragileAIQ Comparison Conviction 2/10

IBM leads

IBM leads by 3 AIQ points, primarily on Value and Momentum, having only recently taken the lead back from CSCO. Wall Street currently favors CSCO on target upside.

Fragile: 1 of 6 evidence groups support IBM, the lead recently changed hands, and its current signal state is conflicted.

Evidence agreement: 1 of 6Comparison trend: Reversed
CSCO

Cisco Systems, Inc.

AIQ Score
53/100
AIQ Edge Score
6/10
IBM

International Business Machines Corporation

Leads
AIQ Score
56/100
AIQ Edge Score
7/10

The Algovestiq AIQ Score currently favors IBM over CSCO, 56 versus 53 as of Sep 2, 2026. IBM's advantage is driven primarily by stronger value and momentum, while CSCO holds the stronger quality profile. IBM also shows the stronger technical structure relative to its 50-day moving average, though analyst target upside currently favors CSCO. 1 of 6 covered evidence groups favor IBM today, and the comparison is rated Fragile on stability: the AIQ gap is narrow at 3 points. IBM lead: Reversed — CSCO led by 5 AIQ points 30 sessions ago; IBM now leads by 3.

Compare Cisco Systems, Inc. and International Business Machines Corporation across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.

AIQ Factor Divergence

Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.

CSCO advantage
0
IBM advantage
  • Value30%49 vs 67
    IBM +18
  • Quality30%74 vs 61
    CSCO +13
  • Momentum25%31 vs 41
    IBM +10
  • Risk Resilience15%55 vs 48
    CSCO +7

1 of 6 evidence groups favor IBM. IBM’s edge is concentrated in value and momentum; CSCO keeps a meaningful quality edge.

What changed since the last close

Latest scored session 2026-09-01, compared against the prior scored session 2026-08-31.

CSCO0 AIQ

No factor moved materially.

No new signals fired.

IBM0 AIQ

No factor moved materially.

No new signals fired.

IBM's lead was unchanged in the latest snapshot.

Deeper signal detail for each name lives on its own signals page — CSCO and IBM both carry a full feed there.

The central trade-off

IBM (International Business Machines Corporation): the stronger current systematic profile, led by value and momentum.

CSCO (Cisco Systems, Inc.): the counter-case, on quality, risk resilience, fundamentals — but at materially higher volatility, 40.4% against 29%.

The AIQ Score and Wall Street therefore point in different directions on this pair.

Which one fits your objective

The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.

Balanced

IBM

IBM on the overall AIQ Score, which weights Quality and Value at 30% each.

Growth

IBM

IBM on combined revenue and EPS growth.

Value

IBM

IBM on the peer-relative Value factor, by 18 points.

Momentum

IBM

IBM on the Momentum factor, by 10 points.

Lower downside

CSCO

CSCO on Risk Resilience, by 7 points.

Analyst upside

CSCO

CSCO on implied upside to the consensus price target.

AIQ vs Wall Street

The model and the Street disagree here: AIQ favors IBM, analyst targets favor CSCO. That disagreement is the most useful thing on this page.

MeasureCSCOIBMNote
Implied upside to target+20%+15.8%CSCO has more room
Target dispersion+30.7%+65%Lower is tighter analyst agreement
ConsensusBuyBuyContext, not a primary driver
Analysts covering1113Higher coverage generally improves confidence

The two are measuring different things. The AIQ Score reads current fundamentals, valuation, trend and risk; analyst targets price forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something already priced in — it is worth resolving before acting on either.

Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.

AIQ Agreement Matrix

1 of 6 covered evidence groups favor IBM. A wide gap backed by one group is a weaker case than a narrow gap backed by five.

Evidence groupFavorsReading
AIQ ScoreEven53 vs 56
FundamentalsCSCOon balancerevenue growth 8.9% vs 7.8%; EPS growth 15.3% vs 76.9%; ROE 25.1% vs 33.5%; gross margin 64.3% vs 58.4%; operating margin 23.4% vs 17.9% — CSCO takes 3 of 5 decided legs, not all of them
ValuationIBMValue 49 vs 67
TechnicalsCSCOPrice vs 50-day -5.8% vs -4.5%; vs 200-day 17.4% vs -11.3%
Risk ResilienceCSCORisk Resilience 55 vs 48
Analyst expectationsCSCOTarget upside 20% vs 15.8%

✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of CSCO and IBM and are excluded from the count.

AIQ Decision Stability

Fragile

The conclusion is sensitive to small changes. Treat the lead as provisional and watch the flip conditions below.

  • The AIQ gap is narrow at 3 points. (argues the conclusion is provisional)
  • Only 1 of 6 covered evidence groups agree. (argues the conclusion is provisional)
  • The lead has already changed hands inside the comparison window. (argues the conclusion is provisional)
  • The leader is throwing conflicting signals. (argues the conclusion is provisional)
  • Analyst targets on the leader are widely dispersed. (argues the conclusion is provisional)

Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on IBM.

How the comparison changed

120 daily snapshots · Apr 20 Sep 1

IBM lead: Reversed — CSCO led by 5 AIQ points 30 sessions ago; IBM now leads by 3.

Apr 20CSCO leads above the line · IBM leads belowSep 1
Today
IBM +3
53 vs 56
7 sessions ago
IBM +4
53 vs 57
30 sessions ago
CSCO +5
66 vs 61
90 sessions ago
CSCO +3
56 vs 53

The lead changed hands 4 times in this window, most recently on Aug 13 when IBM moved ahead of CSCO.

AIQ Signal Divergence

Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.

CSCOConflicted

1 bullish / 1 bearish, conflicted

  • Golden Cross Active bullish, trend, long horizon (22.38%)
  • MACD Bearish Crossover bearish, momentum, short horizon
IBMConflicted

1 bullish / 2 bearish, conflicted

  • Death Cross Active bearish, trend, long horizon (8.34%)
  • Downtrend Structure Active bearish, trend, long horizon
  • MACD Bullish Crossover bullish, momentum, short horizon

IBM leads the comparison while carrying a conflicted signal state, which is one reason the stability rating is not higher.

Price vs model alignment

Whether the latest session's price move confirms what the model did over the same session, or contradicts it.

CSCONo material change

Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price -1.13%, AIQ 0 points).

IBMNo material change

Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price +0.46%, AIQ 0 points).

What would flip this result

A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.

  1. 1CSCO closes the Value gap — currently 18 points behind, the largest single contributor to IBM's edge.
  2. 2CSCO's MACD Bearish Crossover resolves — a bearish momentum rule currently active against it.
  3. 3IBM's conflicting signal state resolves bearish — it currently carries 1 bullish and 2 bearish rules at once.
  4. 4A regime shift changes factor weighting — the composite weights Quality and Value at 30% each, so a rotation toward either would move the result most.

The full evidence

Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.

Fundamentals

CSCO leads on balance
MetricCSCOIBM
Revenue growth (YoY)8.9%7.8%
EPS growth (YoY)15.3%76.9%
Gross margin64.3%58.4%
Operating margin23.4%17.9%
Return on equity25.1%33.5%
Debt to equity0.641.89

Technicals

CSCO has the stronger structure
MetricCSCOIBM
RSI (14)3245.6
ADX (14)2310.2
Price vs 50-day-5.8%-4.5%
Price vs 200-day17.4%-11.3%
Volatility (1M, annualized)40.4%29%

Risk

CSCO is the more resilient
MetricCSCOIBM
Beta1.030.89
Sharpe ratio1.430.07
Sortino ratio1.850.08
Max drawdown-15.7%-37.5%
Current drawdown-15%-29%
Annualized volatility33.9%48.5%
Value at risk (95%)-2.8%-3.3%

Straight answers

Each answer is regenerated from the current snapshot, not written once and left to age.

Which is better, CSCO or IBM?

On the Algovestiq AIQ Score, IBM is the stronger of the two as of Sep 2, 2026, scoring 56 against CSCO's 53. The edge comes from value and momentum. CSCO is not without a case — it holds the better quality profile, which matters more if that is the objective you are optimizing for. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.

Is CSCO or IBM the better buy right now?

IBM carries the stronger systematic profile as of Sep 2, 2026, and the comparison is rated Fragile — 1 of 6 covered evidence groups agree. A Fragile rating means the conclusion is sensitive: the AIQ gap is narrow at 3 points. Treat the lead as provisional.

Why does the AIQ Score favor IBM over CSCO?

The composite weights Quality at 30%, Value at 30%, Momentum at 25% and Risk Resilience at 15%. IBM leads Value by 18 points; CSCO leads Quality by 13 points; IBM leads Momentum by 10 points. Where the two split, the factor with the larger weight carries the result.

Which has more analyst upside, CSCO or IBM?

Analyst price targets imply +20% upside for CSCO and +15.8% for IBM, so the Street currently favors CSCO. That points the opposite way to the AIQ Score, which favors IBM. The two are measuring different things: the model reads current fundamentals, valuation, trend and risk; the Street is pricing forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something the analysts have already priced — it is the single most useful row on this page to investigate. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.

Which is better value, CSCO or IBM?

IBM is the better-valued of the two on the peer-relative Value factor. IBM on the peer-relative Value factor, by 18 points. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.

Which has stronger growth, CSCO or IBM?

IBM on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.

Which has stronger momentum, CSCO or IBM?

IBM on the Momentum factor, by 10 points. Momentum carries 25% of the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.

Which is riskier, CSCO or IBM?

CSCO is the more resilient of the two, so the other name carries the higher downside risk. CSCO on Risk Resilience, by 7 points. The Risk Resilience factor weights 15% of the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.

Is CSCO more profitable than IBM?

The profitability evidence is mixed: gross margin 64.3% vs 58.4%; operating margin 23.4% vs 17.9%; roe 25.1% vs 33.5%. CSCO leads on two measures and IBM on one measure, and there is no single profitability composite that resolves the split — which of the two reads as "more profitable" depends on whether you weight pricing power or operating leverage.

Is IBM's lead over CSCO getting stronger or weaker?

IBM lead: Reversed — CSCO led by 5 AIQ points 30 sessions ago; IBM now leads by 3. This is measured from 120 daily comparison snapshots between 2026-04-20 and 2026-09-01. The lead has changed hands 4 times in that window, most recently on 2026-08-13, when IBM moved ahead of CSCO.

What would change the CSCO vs IBM verdict?

The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: CSCO closes the Value gap — currently 18 points behind, the largest single contributor to IBM's edge; CSCO's MACD Bearish Crossover resolves — a bearish momentum rule currently active against it; IBM's conflicting signal state resolves bearish — it currently carries 1 bullish and 2 bearish rules at once; a regime shift changes factor weighting — the composite weights Quality and Value at 30% each, so a rotation toward either would move the result most.

What do the current signals say about CSCO and IBM?

CSCO: 1 bullish / 1 bearish, conflicted. IBM: 1 bullish / 2 bearish, conflicted. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on CSCO is Golden Cross Active (bullish, long horizon). On IBM it is Death Cross Active (bearish, long horizon).

Compare CSCO and IBM with others

How this comparison is scored

The Algovestiq AIQ Score composites four factors — Quality (30%), Value (30%), Momentum (25%) and Risk (15%). Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.

The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.

How to use side-by-side comparison →

This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.